Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,253,826
in 9 filings, $2.1M under 10b5-1 plans

Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-13 Watanabe Todd Franklin Director Sale −441 $17.00 $7K 377,466
2023-02-13 Watanabe Todd Franklin Director Sale −42 $17.01 $714 377,424
2023-02-01 Watanabe Todd Franklin Director Sale −618 $17.00 $11K 378,289
2023-02-01 Watanabe Todd Franklin Director Sale −382 $17.00 $6K 377,907
2023-01-17 Welgus Howard G. Director Exercise or conversion +8,500 $1.68 $14K 174,325
2023-01-17 Welgus Howard G. Director Sale −8,500 $13.72 $117K 165,825
2023-01-17 Welgus Howard G. Director Exercise or conversion · Stock Option (right to buy) −8,500 31,958
2023-01-03 Burnett Patrick Sale −1,475 $15.01 $22K 41,564
2022-12-07 Watanabe Todd Franklin Director Sale −1,000 $17.06 $17K 378,907
2022-11-21 Matsuda Masaru Sale −1,720 $18.19 $31K 19,535
2022-11-18 Matsuda Masaru Grant or award +4,875 21,255
2022-11-15 Welgus Howard G. Director Exercise or conversion +1,020 $1.68 $2K 169,228
2022-11-15 Welgus Howard G. Director Sale −3,403 $20.01 $68K 165,825
2022-11-15 Welgus Howard G. Director Exercise or conversion · Stock Option (right to buy) −1,020 40,458
2022-11-07 Watanabe Todd Franklin Director Sale −1,000 $18.00 $18K 379,907
2022-10-07 Watanabe Todd Franklin President and CEO Sale −1,000 $19.51 $20K 380,907
2022-10-04 Welgus Howard G. Director Sale −6,000 $20.29 $122K 168,208
2022-09-16 Burrows Scott L Chief Financial Officer Exercise or conversion +5,000 $1.68 $8K 40,256
2022-09-16 Burrows Scott L Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −5,000 37,277
2022-09-07 Watanabe Todd Franklin President and CEO Sale −1,000 $21.51 $22K 381,907

Page 27 of 35 · 689 trades